{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:39:33Z","timestamp":1787693973966,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"vor","delay-in-days":390,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1038\/mtna.2016.47","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T11:22:44Z","timestamp":1467717764000},"page":"e331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Francesco","family":"Catapano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Zaharieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Scoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2016.47_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/joa.12083","article-title":"Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?","volume":"224","author":"Shababi","year":"2014","journal-title":"J Anat"},{"key":"10.1038\/mtna.2016.47_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mtna.2016.47_bib3","doi-asserted-by":"crossref","first-page":"e62114","DOI":"10.1371\/journal.pone.0062114","article-title":"Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy","volume":"8","author":"Mitrpant","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib4","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2016.47_bib5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/hum.2012.211","article-title":"A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice","volume":"24","author":"Zhou","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2016.47_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2016.47_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2016.47_bib10","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2016.47_bib11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1038\/mtna.2016.47_bib12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1038\/mtna.2016.47_bib13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1038\/mtna.2016.47_bib14","doi-asserted-by":"crossref","first-page":"e80263","DOI":"10.1371\/journal.pone.0080263","article-title":"Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy","volume":"8","author":"Zaharieva","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib15","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/mtna.2012.26","article-title":"Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy","volume":"1","author":"Roberts","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mtna.2016.47_bib16","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1093\/nar\/gkt724","article-title":"Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover","volume":"41","author":"Roberts","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2016.47_bib17","doi-asserted-by":"crossref","first-page":"e55281","DOI":"10.1371\/journal.pone.0055281","article-title":"Distinctive serum miRNA profile in mouse models of striated muscular pathologies","volume":"8","author":"Vignier","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","article-title":"Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding","volume":"162","author":"McWhorter","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1038\/mtna.2016.47_bib19","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"miRNA malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.47_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nn.3082","article-title":"microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons","volume":"15","author":"Dajas-Bailador","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1038\/mtna.2016.47_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.expneurol.2011.11.041","article-title":"Dicer-microRNA pathway is critical for peripheral nerve regeneration and functional recovery in vivo and regenerative axonogenesis in vitro","volume":"233","author":"Wu","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1038\/mtna.2016.47_bib22","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.1015691107","article-title":"microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus","volume":"107","author":"Magill","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.47_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.neuroscience.2009.11.057","article-title":"Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression","volume":"165","author":"Kawashima","year":"2010","journal-title":"Neuroscience"},{"key":"10.1038\/mtna.2016.47_bib24","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1242\/dev.078063","article-title":"Convergent repression of Foxp2 3\u2032UTR by miR-9 and miR-132 in embryonic mouse neocortex: implications for radial migration of neurons","volume":"139","author":"Clovis","year":"2012","journal-title":"Development"},{"key":"10.1038\/mtna.2016.47_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.2186","article-title":"MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis","volume":"16","author":"Anand","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/mtna.2016.47_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nmd.2011.10.021","article-title":"Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy","volume":"22","author":"Somers","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/mtna.2016.47_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.24549","article-title":"Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy","volume":"79","author":"Somers","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1038\/mtna.2016.47_bib28","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1093\/hmg\/ddu142","article-title":"Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy","volume":"23","author":"Boyer","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib29","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1093\/hmg\/ddu189","article-title":"Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics","volume":"23","author":"Bricceno","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.200603008","article-title":"Muscle-specific microRNA miR-206 promotes muscle differentiation","volume":"174","author":"Kim","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1038\/mtna.2016.47_bib31","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","article-title":"MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice","volume":"326","author":"Williams","year":"2009","journal-title":"Science"},{"key":"10.1038\/mtna.2016.47_bib32","doi-asserted-by":"crossref","first-page":"e93140","DOI":"10.1371\/journal.pone.0093140","article-title":"The role of muscle microRNAs in repairing the neuromuscular junction","volume":"9","author":"Valdez","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib33","doi-asserted-by":"crossref","first-page":"e89065","DOI":"10.1371\/journal.pone.0089065","article-title":"MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis","volume":"9","author":"Toivonen","year":"2014","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib34","doi-asserted-by":"crossref","first-page":"e0128560","DOI":"10.1371\/journal.pone.0128560","article-title":"Expression of muscle-specific MiRNA 206 in the progression of disease in a murine SMA model","volume":"10","author":"Valsecchi","year":"2015","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/mtna.2016.47_bib36","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","article-title":"Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fncel.2013.00220","article-title":"miR-9: a versatile regulator of neurogenesis","volume":"7","author":"Coolen","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1038\/mtna.2016.47_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1038\/mtna.2016.47_bib39","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science"},{"key":"10.1038\/mtna.2016.47_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.kjms.2013.12.007","article-title":"Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy","volume":"30","author":"Wang","year":"2014","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1038\/mtna.2016.47_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mtna.2016.47_bib42","doi-asserted-by":"crossref","first-page":"e18388","DOI":"10.1371\/journal.pone.0018388","article-title":"Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy","volume":"6","author":"Mizuno","year":"2011","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib43","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2016.47_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","volume":"19","author":"Hamilton","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1038\/mtna.2016.47_bib45","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/hmg\/ddt612","article-title":"SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy","volume":"23","author":"Hunter","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/hmg\/ddu447","article-title":"Motoneuron development influences dorsal root ganglia survival and Schwann cell development in a vertebrate model of spinal muscular atrophy","volume":"24","author":"le Hao","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mtna.2016.47_bib47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpeds.2009.01.071","article-title":"Vascular perfusion abnormalities in infants with spinal muscular atrophy","volume":"155","author":"Araujo","year":"2009","journal-title":"J Pediatr"},{"key":"10.1038\/mtna.2016.47_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mus.21654","article-title":"Digital necroses and vascular thrombosis in severe spinal muscular atrophy","volume":"42","author":"Rudnik-Sch\u00f6neborn","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1038\/mtna.2016.47_bib49","doi-asserted-by":"crossref","first-page":"e0155032","DOI":"10.1371\/journal.pone.0155032","article-title":"Histopathological defects in intestine in severe spinal muscular atrophy mice are improved by systemic antisense oligonucleotide treatment","volume":"11","author":"Sintusek","year":"2016","journal-title":"PLoS One"},{"key":"10.1038\/mtna.2016.47_bib50","first-page":"1","article-title":"MicroRNAs and endothelial (Dys) function","volume":"9999","author":"Santulli","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1038\/mtna.2016.47_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/FJC.0000000000000178","article-title":"MicroRNA signature and cardiovascular dysfunction","volume":"65","author":"Arunachalam","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/mtna.2016.47_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/nyas.12758","article-title":"MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets","volume":"1353","author":"Kato","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/mtna.2016.47_bib53","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117300604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253117300604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:31:03Z","timestamp":1761874263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253117300604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":53,"alternative-id":["S2162253117300604"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2016.47","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Levels of MicroRNA-9, -206, and -132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mtna.2016.47","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Official journal of the American Society of Gene & Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e331"}}